Your typical health care visit used to consist of driving to a clinic or office, filing out some paperwork, and waiting for someone to call your name when your provider was ready for you.
Then, the coronavirus hit. Suddenly many people were attending appointments on the computer or over the phone, and
telehealth became a household word.
While telehealth appointments have been around for decades, they were on the periphery of the health care system. After the pandemic made it impossible to deliver health care in the same ways as before, telehealth became necessary, and barriers to reimbursement, technology, and licensure began to fall. Some health systems had to move from small-scale telehealth implementation to 100 percent virtual encounters overnight. Patients soon began seeing their doctors from within their own homes. Even in the inpatient setting, they increasingly interacted with health care providers through iPads. Telehealth’s recent progress is something “that most pe
Elizabeth McGraw named head of Department of Biology
Elizabeth McGraw has been named the head of Penn State s Department of Biology, effective April 1. Image: Patrick Mansell, Penn State
Elizabeth McGraw named head of Department of Biology
Gail McCormick
February 25, 2021
UNIVERSITY PARK, Pa. Elizabeth McGraw, professor and Huck Scholar in Entomology and director of the Center for Infectious Disease Dynamics (CIDD) at Penn State, has been named the new head of the Department of Biology, effective April 1.
“Beth is an accomplished scholar and brings a keen commitment to advocacy and excellence, and to furthering the success of students, postdocs, faculty and staff,” said Tracy Langkilde, Verne M. Willaman Dean of the Eberly College of Science. “I am confident that she will provide strong and effective leadership to the department.”
By Jim Shelton
February 24, 2021
Share this with FacebookShare this with TwitterShare this with LinkedInShare this with EmailPrint this
Yale scientists have developed a new class of antiviral agents that shows promise for creating COVID-19 therapeutics exhibiting particular effectiveness when used in tandem with the drug remdesivir, another antiviral medication approved for use against the virus.
The new compounds are the first potent, drug-like, non-covalent, and non-peptidic inhibitors of the main protease, or enzyme, in SARS-CoV-2 that is crucial for processing essential viral proteins. A study demonstrating the compounds appears in the journal ACS Central Science.
The work is the latest collaboration of Yale researchers William Jorgensen and Karen Anderson, senior co-authors of the study, who use high-level computation and structural biology methods to design compounds that target viral proteins.
Online Experts on Withdrawal
Online forums have emerged to help people who are navigating withdrawal alone
Online peer support forums offer people taking psychiatric medication valuable information and advice about withdrawal. Such online communities help us understand withdrawal as an integral part of mental health treatment and recovery. This article argues that it is necessary to validate this new resource so that this content is accessible not only to patients, but also to prescribers.
Many patients who choose to discontinue psychiatric medication end up pursuing withdrawal without their prescriber’s guidance. Some patients start the withdrawal process with their clinician, but, when these attempts are unsuccessful, they end up pursuing withdrawal without professional help. Others try to withdraw without ever seeking their prescribers’ assistance in the first place. Some people are eventually able to get off their medication, although often with difficulty. Others are no